Anette Lindqvist
Director of Finance/CFO bei XBRANE BIOPHARMA AB
Vermögen: 5 100 $ am 31.03.2024
Aktive Positionen von Anette Lindqvist
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
XBRANE BIOPHARMA AB | Director of Finance/CFO | 11.01.2021 | - |
Investor Relations Contact | 11.01.2021 | - | |
Nanolyze AB
Nanolyze AB Miscellaneous Commercial ServicesCommercial Services Nanolyze AB develops bio analytical technology. The company is based in Mölndal, Sweden. Nils Löfgren has been the CEO of the Swedish company since 2020. | Chairman | - | - |
Karriereverlauf von Anette Lindqvist
Ehemalige bekannte Positionen von Anette Lindqvist
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MEDIVIR AB | Director/Board Member | 05.05.2022 | 20.10.2023 |
SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - | - |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - | - |
COMBINEDX AB | Director/Board Member | 01.01.2018 | - |
Ausbildung von Anette Lindqvist
University of Gothenburg | Undergraduate Degree |
Statistik
International
Schweden | 8 |
Operativ
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Director of Finance/CFO | 1 |
Sektoral
Health Technology | 4 |
Commercial Services | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
MEDIVIR AB | Health Technology |
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
XBRANE BIOPHARMA AB | Health Technology |
COMBINEDX AB | Commercial Services |
Private Unternehmen | 2 |
---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Nanolyze AB
Nanolyze AB Miscellaneous Commercial ServicesCommercial Services Nanolyze AB develops bio analytical technology. The company is based in Mölndal, Sweden. Nils Löfgren has been the CEO of the Swedish company since 2020. | Commercial Services |
- Börse
- Insiders
- Anette Lindqvist
- Erfahrung